These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1657912)

  • 21. Modulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by azole antimycotics requires lanosterol demethylation, but not 24,25-epoxylanosterol formation.
    Favata MF; Trzaskos JM; Chen HW; Fischer RT; Greenberg RS
    J Biol Chem; 1987 Sep; 262(25):12254-60. PubMed ID: 3624255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol starvation decreases p34(cdc2) kinase activity and arrests the cell cycle at G2.
    Martínez-Botas J; Suárez Y; Ferruelo AJ; Gómez-Coronado D; Lasuncion MA
    FASEB J; 1999 Aug; 13(11):1359-70. PubMed ID: 10428760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation in lovastatin-resistant cells.
    Ravid T; Avner R; Polak-Charcon S; Faust JR; Roitelman J
    J Biol Chem; 1999 Oct; 274(41):29341-51. PubMed ID: 10506194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells.
    Nagata Y; Hidaka Y; Ishida F; Kamei T
    Biochem Pharmacol; 1990 Aug; 40(4):843-50. PubMed ID: 2167097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apomine, a novel hypocholesterolemic agent, accelerates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and stimulates low density lipoprotein receptor activity.
    Roitelman J; Masson D; Avner R; Ammon-Zufferey C; Perez A; Guyon-Gellin Y; Bentzen CL; Niesor EJ
    J Biol Chem; 2004 Feb; 279(8):6465-73. PubMed ID: 14627708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of sterol synthesis by the monoterpene perillyl alcohol is unaffected by competitive 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
    Cerda SR; Wilkinson J; Branch SK; Broitman SA
    Lipids; 1999 Jun; 34(6):605-15. PubMed ID: 10405975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties.
    Trzaskos JM; Ko SS; Magolda RL; Favata MF; Fischer RT; Stam SH; Johnson PR; Gaylor JL
    Biochemistry; 1995 Aug; 34(30):9670-6. PubMed ID: 7626636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A relationship between the activities of hepatic lanosterol 14 alpha-demethylase and 3-hydroxy-3-methylglutaryl-CoA reductase.
    Marco de la Calle C; Hwang W; Pullinger CR; Gibbons GF
    Biochem J; 1988 Feb; 250(1):33-9. PubMed ID: 3355520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis in p53-null HL-60 cells by inhibition of lanosterol 14-alpha demethylase.
    Martínez-Botas J; Ferruelo AJ; Suárez Y; Gómez-Coronado D; Lasunción MA
    Biochimie; 1998 Nov; 80(11):887-94. PubMed ID: 9893947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous sterol synthesis is not required for regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by low density lipoprotein.
    Burki E; Logel J; Sinensky M
    J Lipid Res; 1987 Oct; 28(10):1199-205. PubMed ID: 3681144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4'-(6-allyl-ethyl-amino-hexyloxy)-2'-fluoro-phenyl]-(4-bromophenyl)-me thanone (Ro 48-8071): comparison to simvastatin.
    Peffley DM; Gayen AK; Morand OH
    Biochem Pharmacol; 1998 Aug; 56(4):439-49. PubMed ID: 9763219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.
    Ellsworth JL; Chandrasekaran C; Cooper AD
    Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):175-87. PubMed ID: 1930137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An oxysterol-derived positive signal for 3-hydroxy- 3-methylglutaryl-CoA reductase degradation in yeast.
    Gardner RG; Shan H; Matsuda SP; Hampton RY
    J Biol Chem; 2001 Mar; 276(12):8681-94. PubMed ID: 11134013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2.
    Berkhout TA; Havekes LM; Pearce NJ; Groot PH
    Biochem J; 1990 Nov; 272(1):181-6. PubMed ID: 2176080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway.
    Scharnagl H; Schliack M; Löser R; Nauck M; Gierens H; Jeck N; Wieland H; Gross W; März W
    Atherosclerosis; 2000 Nov; 153(1):69-80. PubMed ID: 11058701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
    Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
    Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS; Panini SR
    Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 32-Methyl-32-oxylanosterols: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Cusack KP; Leonard DA
    J Med Chem; 1993 Feb; 36(3):410-6. PubMed ID: 8426367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation.
    Cuthbert JA; Lipsky PE
    J Biol Chem; 1990 Oct; 265(30):18568-75. PubMed ID: 2211719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.